U.S. markets close in 2 hours 29 minutes

Dolphin Entertainment, Inc. (DLPN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.69+0.14 (+1.64%)
As of 01:25PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close8.55
Bid8.65 x 1200
Ask8.81 x 900
Day's Range8.39 - 8.69
52 Week Range3.20 - 32.50
Avg. Volume220,917
Market Cap69.009M
Beta (5Y Monthly)1.92
PE Ratio (TTM)N/A
EPS (TTM)-0.65
Earnings DateNov 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DLPN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Dolphin Entertainment, Inc.
    Analyst Report: Seagen Inc.Seagen Inc. (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen’s therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer, Tukysa for breast cancer, and Tivdak for cervical cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more

    Dolphin Entertainment Enters Ready to Drink Cocktail Market With Ownership Stake in Crafthouse Cocktails

    MIAMI, FL / ACCESSWIRE / December 8, 2021 / Dolphin Entertainment (NASDAQ:DLPN), a leading independent entertainment marketing and production company, today announced it has entered into a strategic partnership with Crafthouse Cocktails, a pioneering brand of ready-to-drink, all-natural classic cocktails created by world renowned mixologist, Charles Joly and esteemed restaurateur, Matt Lindner. Dolphin will manage all aspects of publicity and marketing for the brand through its network of agenci


    Shore Fire Media’s Twenty-Seven 2022 Grammy Nominations Highlight Breadth of Roster across R&B, Electronic, Global, Roots, Jazz, Comedy, Gospel and More

    Bonobo, Jacob Collier, Rhiannon Giddens, Angelique Kidjo and Maverick City Music Earn Multiple Nominations; Single Lock Records Gets Three Nods; PJ Morton Nominated for Fifth Straight YearNEW YORK, NY / ACCESSWIRE / November 29, 2021 / Shore Fire Media, a subsidiary of Dolphin Entertainment, Inc. (NASDAQ:DLPN), congratulates the clients and projects it represented during the past GRAMMY year who collectively earned twenty-seven nominations, reflecting the breadth of the company's roster across R


    Dolphin Entertainment Announces Creature Chronicles: Exiled Aliens, Its First Generative NFT Collection

    10,000 Unique Avatars Designed by Former Marvel Studios' Artist, Anthony Francisco Collection To Be Minted on the Solana Blockchain Users Can Purchase Directly On-Site With FTX.US WalletNEW YORK, NY / ACCESSWIRE / November 22, 2021 / Dolphin Entertainment (NASDAQ:DLPN) announces the launch of Creature Chronicles: Exiled Aliens, the content studio's first generative NFT (non-fungible token) collection and the initial project from newly-hired visual artist Anthony Francisco.